Cubist recalls Cubicin antibiotic

This is a summary. To read the whole story subscribe to

Cubist Pharmaceuticals Inc., the Lexington biotechnology company, said Thursday it is recalling four lots of its Cubicin antibiotic after glass particles were found in some vials.

Cubist said no adverse events have been reported as a result, but if the particles were to contaminate the drug, it cold pose a safety risk to patients, the company said.

Company spokeswoman Julie DiCarlo said the four lots represented about two weeks of production at one of the company’s two Cubicin manufacturers but is not expected to disrupt overall supplies to patients. Cubist is notifying patients by letter and phone and will replace recalled products. The company has also alerted notified the Food and Drug Administration about the recall.

Full story for subscribers.

Get the full story with unlimited access to

Just 99 cents for four weeks.